Truway Health
Organization
Trials
Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
Phase 1/2, Enrolling by invitation, 120 people, Oct 28, 2025
Truway Diagnostic Tools in Primary Care
Early phase 1, Enrolling by invitation, 200 people, Oct 7, 2025
Sources: clinicaltrials.gov